Dr. Olga Rodriguez, Associate Professor in the Department of Oncology, is the co-founder and co-director of both the Georgetown-Lombardi Preclinical Imaging Research Laboratory (PIRL) and the Center for Translational Imaging. Dr. Rodriguez has an extensive background in clinical medicine, molecular biology, animal modeling and preclinical imaging, work that has resulted in over fifty peer-reviewed publications to date: https://pubmed.ncbi.nlm.nih.gov/collections/59744881/?sort=pubdate . Dr. Rodriguez teaches in both the Department of Oncology and the School of Medicine and runs comprehensive research programs in molecular and cell biology and, with over 15 years of experience in MRI and image post-processing, is instrumental in the translational research performed at Georgetown. Dr. Rodriguez is involved in several collaborative projects that include MR contrast agent development, applications of MRI in traumatic brain and spinal cord injury, adult and childhood cancers, stroke, epilepsy, as well as kidney and liver disease. One of Dr. Rodriguez’s current interests is to define the impact of chemotherapy on brain structure and function in the intersection of aging, sex and the genetic risk of the E4 allele. Dr. Rodriguez is a leader in enhancing equity, inclusion and diversity at Georgetown in two fronts: 1) as a member of the Racial Justice Committee for Change which seeks, among other things, to make the School of Medicine curriculum more representative of the US population and, 2) as the director of the Medical Spanish Initiative, which trains medical students to communicate effectively with their Spanish-speaking patients in a culturally-sensitive manner.